A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at RiskMaría J. Redondo, Francine Kaufman, Richard A. Oram et al.|Diabetes Care|2018Cited by 174
Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial DataMichael J. Haller, Louis H. Philipson, S. Alice Long et al.|Diabetes|2019Cited by 132
The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screeningLaura M. Jacobsen, Jay M. Sosenko, Laura E. Bocchino et al.|Diabetologia|2019Cited by 130
The Bayesian basket design for genomic variant-driven phase II trialsRichard Simon, Sameek Roychowdhury, Susan Geyer et al.|Seminars in Oncology|2016Cited by 97
Graded Organ Response and Progression Criteria for Kidney Immunoglobulin Light Chain AmyloidosisEli Muchtar, Morie A. Gertz, Brendan Wisniowski et al.|JAMA Oncology|2024Cited by 30